CG Oncology (CGON) FCF Margin (2023 - 2026)

CG Oncology posted quarterly FCF Margin of 5281.99% for Q1 2026, up 5105070.0% year-on-year from N/an in Q1 2025, and down 238.31% on a QoQ basis from 1561.28% in Q4 2025.

CG Oncology (CGON) has 4 years of FCF Margin data on file, last reported at 5281.99% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin rose 5105070.0% year-over-year to 5281.99%; the trailing twelve-month figure through Mar 2026 stood at 3162.91% (up 925643.0% YoY), and the FY2025 full-year result was 3279.21%, up 365205.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 5281.99%, down from 1561.28% in the prior quarter.
  • Across five years, FCF Margin topped out at 1561.28% in Q4 2025 and bottomed at 1464500.0% in Q4 2023.
  • The 4-year median for FCF Margin is 5281.99% (2026), against an average of 157402.53%.
  • The widest annual swing landed in 2024, when FCF Margin surged 145992303 bps; it then slumped 5141322 bps in 2025.
  • A 4-year view of FCF Margin shows it stood at 1464500.0% in 2023, then surged by 100 bps to 4576.97% in 2024, then soared by 66 bps to 1561.28% in 2025, then tumbled by 238 bps to 5281.99% in 2026.
  • The last three FCF Margin figures came in at 5281.99% (Q1 2026), 1561.28% (Q4 2025), and 2340.76% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 43.35%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.17%
10 CG Oncology 5.01 Bn 5.01 Bn -1.88 Mn -5,281.99%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5,281.99%
Dec 31, 2025 -1,561.28%
Sep 30, 2025 -2,340.76%
Mar 31, 2025 -56,332.69%
Dec 31, 2024 -4,576.97%
Sep 30, 2024 -37,018.60%
Jun 30, 2024 -14,535.14%
Mar 31, 2024 -4,919.47%
Dec 31, 2023 -1,464,500.00%
Sep 30, 2023 -136,244.44%
Mar 31, 2023 -4,116.49%